IIPR Q3 2026 slides: life sciences push drives diversification

Innovative Industrial Properties (IIPR) reported its Q3 2026 results on November 3, 2026, highlighting a strategic shift towards life sciences investments while retaining its cannabis real estate focus. The specialized REIT showcased strong performance, with revenue of $64.9 million exceeding analyst estimates. The company's stock rose 1.31% to $55.12, trading within its 52-week range.

IIPR's dividend yield is approximately 14%, and its P/E ratio is 12.5. The company aims to reduce concentration risk in the cannabis sector, with life science investments now totaling $545 million, accounting for 20.8% of annualized income. Notable investments include a $100 million revolving credit facility and a $245 million mezzanine loan for a life science campus in Cambridge, Massachusetts.

The company's current portfolio is 79% cannabis, but management expects the mix to shift toward life sciences over time.